Rochester, NY 8/20/2009 8:19:13 PM
Tianyin Pharmaceutical Co., Inc. TPI - Tianyin Pharma Shares Increase with 32%
Tianyin Pharmaceutical Co., Inc. TPI
Tianyin Pharmaceutical Co. TPI last Wednesday announces had already more than double this year. The company shares jumped 32% to $4.35 in premarket trading. The company announced it had been cleared by the Chinese State Food and Drug Administration to make generic forms of medicines to treat internal bleeding and respiratory ailments.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Sanqi tablets are used to treat injury-related bleeding and reduce swelling and pain. Tianyin expects producing the tablets - which have estimated annual Chinese sales of about $73.5 million - will help it gain a share of the Chinese orthopedic-medicine market. A feature of Sanqi is it does not cause blood stasis, or blood stagnation, an important underlying pathology of many disease processes, according to traditional Chinese medicine.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.